<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Helei</forename><surname>Hou</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">State Key Laboratory of Oncogenes and Related Genes</orgName>
								<orgName type="institution">Shanghai Cancer Institute</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Renji Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiaotong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Medical Oncology</orgName>
								<orgName type="institution">The Affiliated Hospital of Qingdao University</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Qingdao University</orgName>
								<address>
									<settlement>Qingdao</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Chao Ge</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">State Key Laboratory of Oncogenes and Related Genes</orgName>
								<orgName type="institution">Shanghai Cancer Institute</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Renji Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiaotong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hefen</forename><surname>Sun</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">State Key Laboratory of Oncogenes and Related Genes</orgName>
								<orgName type="institution">Shanghai Cancer Institute</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Renji Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiaotong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hong</forename><surname>Li</surname></persName>
							<affiliation key="aff0">
								<orgName type="laboratory">State Key Laboratory of Oncogenes and Related Genes</orgName>
								<orgName type="institution">Shanghai Cancer Institute</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Renji Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiaotong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jinjun</forename><surname>Li</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Hua</forename><surname>Tian</surname></persName>
							<email>htian@shsci.org</email>
							<idno type="ORCID">0000-0002-2316-1953</idno>
							<affiliation key="aff0">
								<orgName type="laboratory">State Key Laboratory of Oncogenes and Related Genes</orgName>
								<orgName type="institution">Shanghai Cancer Institute</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Renji Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiaotong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff0">
								<orgName type="laboratory">State Key Laboratory of Oncogenes and Related Genes</orgName>
								<orgName type="institution">Shanghai Cancer Institute</orgName>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Renji Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiaotong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="laboratory">State Key Laboratory of Oncogenes and Related Genes</orgName>
								<orgName type="institution" key="instit1">Shanghai Cancer Institute</orgName>
								<orgName type="institution" key="instit2">Renji Hospital</orgName>
								<orgName type="institution" key="instit3">Shanghai Jiaotong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution" key="instit1">the Foundation of Renji Hospital</orgName>
								<orgName type="institution" key="instit2">Shanghai Jiao Tong University</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">B1116D18500D4ECD628E9BF9774FFE24</idno>
					<idno type="DOI">10.1111/cas.13518</idno>
					<note type="submission">Received: 14 September 2017 | Revised: 2 January 2018 | Accepted: 22 January 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:29+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>CD44s</term>
					<term>EMT</term>
					<term>ERK1/2</term>
					<term>hepatocellular carcinoma</term>
					<term>tunicamycin</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Tunicamycin (TM) is an N-linked glycosylation (NLG) inhibitor with strong antitumor activity, the exact underlying molecular mechanism of which remains to be elucidated.</s></p><p><s>In our previous studies, we found that TM reversed drug resistance and improved the efficacy of combination treatments for hepatocellular carcinomas (HCC).</s><s>Here, we investigated the effects of TM on HCC cell proliferation and migration as well as the mechanism of those effects.</s><s>Our results showed that TM inhibited cell proliferation and migration as well as induced apoptosis of hepatocellular carcinoma cells.</s><s>TM inhibited proliferation of HCC cells by inducing cell apoptosis and cell cycle arrest at the G2/M phase.</s><s>Meanwhile, TM inhibited migration of HCC cells by suppressing CD44s-mediated epithelial-mesenchymal transition (EMT).</s><s>TM inhibited migration and invasion of HCC cells by decreasing CD44 expression and altering its glycosylation.</s><s>In addition, CD44s is involved in promoting EMT and is associated with a poor prognosis in HCC patients.</s><s>Overexpression of CD44s promoted tumor migration and activated phosphorylation of ERK1/2 in HCC cells, whereas TM inhibited CD44s overexpression-associated cell migration.</s><s>The ability of TM to inhibit cell migration and invasion was enhanced or reversed in CD44s knockdown cells and cells overexpressing CD44s, respectively.</s><s>The MEK/ERK inhibitor U0126 and TM inhibited hyaluronic acid-induced cell migration in HCC cells.</s><s>Furthermore, TM inhibited exogenous transforming growth factor beta (TGF-b)-mediated EMT by an ERK1/2dependent mechanism and restored the TGF-b-mediated loss of E-cadherin.</s><s>In summary, our study provides evidence that TM inhibits proliferation and migration of HCC cells through inhibition of CD44s and the ERK1/2 signaling pathway.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Acquisition of migratory and invasive capability is the initial step in metastasis.</s><s>Epithelial-mesenchymal transition (EMT) is proposed to be a crucial mechanism that regulates the initial steps of metastatic progression. <ref type="bibr" target="#b3">4</ref></s><s>CD44, a major adhesion molecule of the extracellular matrix, has been implicated in a wide variety of physiological processes, including leukocyte homing and activation, wound healing, and cell migration. <ref type="bibr" target="#b4">5</ref></s><s>A previous study showed that CD44 alternative splicing is differentially regulated during EMT, resulting in a switch in expression from the variable exon-containing CD44v isoform to the standard isoform, CD44s, which is devoid of all CD44 variable exons. <ref type="bibr" target="#b5">6</ref></s><s>Furthermore, a previous study showed that up-regulation of CD44 isoforms is associated with poorly differentiated HCC and shortened survival. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref></s><s>Linked glycosylation (NLG) is believed to play a central role in sustaining protein stability, trafficking, and function.</s><s>Tunicamycin (TM) potently inhibits NLG by competitively inhibiting DPAGT1 activity and can target several types of tumors by reducing angiogenesis, inhibiting colony formation, and enhancing TRAIL-induced apoptosis.</s><s><ref type="bibr" target="#b8">9</ref> Recently, we found that TM can reverse drug resistance and improve the efficacy of combination treatments for HCC by targeting the DPAGT1/Akt/ABCG2 pathway.</s><s><ref type="bibr" target="#b9">10</ref> However, the effects of TM on the proliferation and migration of HCC cells are unknown.</s></p><p><s>In the present study, we investigated the effect of TM on the proliferation and migration of HCC cells as well as the underlying molecular mechanisms of these processes.</s><s>We found that TM inhibits the proliferation and migration of HCC cells through CD44s and the ERK1/2 pathway.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">| MATERIALS AND METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">| Cell lines and cell culture</head><p><s>MHCC-97L and MHCC-97H were kindly provided by the Liver Cancer Institute of Zhongshan Hospital, Fudan University (Shanghai, China).</s><s>SMMC-7721 and L02 were obtained from the Cell Bank of the Institute of Biochemistry and Cell Biology, China Academy of Sciences (Shanghai, China).</s><s>HEK-293T was purchased from the ATCC (Manassas, VA, USA).</s><s>Human primary HCC-LY5 cell lines established in our laboratory were cultured in Williams' Medium E supplemented with 10% FBS.</s><s>The other HCC cell lines used in this study were cultured in DMEM (Sigma-Aldrich, St Louis, MO, USA) containing 10% heat-inactivated FBS (HyClone) and incubated at 37°C in a humidified atmosphere with 5% CO 2 .</s><s>Chemicals and other reagents were purchased from Sigma-Aldrich unless otherwise specified.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">| Cell cycle analysis</head><p><s>For cell cycle analysis, cells were plated in a 6-well culture plate and grown for 24 hours.</s><s>Cells were then incubated with 1 mM thymidine (Sigma-Aldrich) or 100 ng/mL nocodazole for 24 hours to synchronize cells at the G1/S or G2/M boundary.</s><s>Cells were then treated with fresh media containing 2.5 lg/mL TM for different lengths of time.</s></p><p><s>Next, cells were trypsinized, washed twice with cold PBS and fixed with cold 70% ethanol at À20°C overnight.</s><s>Cells were then washed twice with PBS and incubated with 10 mg/mL RNase A, 400 mg/mL propidium iodide and 0.1% Triton X in PBS at room temperature (RT) for 30 minutes.</s><s>Cells were subsequently analyzed by flow cytometry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">| Apoptotic assay</head><p><s>Annexin V and 7-AAD staining was used to visualize apoptotic cells according to the manufacturer's instructions.</s><s>Briefly, cells were seeded in 6-well plates and treated with TM at 2.5 lg/mL for 24 hours.</s><s>Cells were then collected, washed twice with PBS and resuspended in 400 mL of 1 9 binding buffer.</s><s>Next, 5 mL Annexin V-PE and 7-AAD solution was added, and the samples were incubated for 15 minutes at RT and analyzed by flow cytometry.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">| MTT assay</head><p><s>Cells (5000/well) were seeded on 96-well plates for 24 hours and then exposed to different concentrations of TM.</s><s>After incubation for 48 hours, 20 mL of 5 mg/mL MTT was added to the medium, and cells were incubated at 37°C for another 4 hours.</s><s>Then the culture medium was discarded and 100 mL DMSO was added to each well to dissolve the precipitate.</s><s>Absorbance (A) was measured at 570 nm using an ELISA plate reader, with background subtraction measurements done at 630 nm.</s><s>The inhibition rate was calculated as follows: Inhibition rate ¼ 1 À ðA570 À A630Þ of treated cells = ðA570 À A630Þ of control cells:</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">| Western blotting</head><p><s>Cell lysates were separated by SDS-PAGE and transferred onto nitrocellulose membranes.</s><s>The membranes were incubated with a primary antibody overnight at 4°C and subsequently probed with HRP-conjugated secondary antibodies.</s><s>Immunoreactive blots were visualized using an ECL reagent (Pierce, Rockford, IL, USA).</s><s>Antibody information is listed in Table <ref type="table">S1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6">| Quantitative real-time RT-PCR</head><p><s>Total RNA extraction, reverse transcription, and quantitative realtime RT-PCR (qRT-PCR) analyses were carried out as previously described using an ABI Prism 7500 System (Applied Biosystems, Carlsbad, CA, USA) with SYBR â Premix Ex Taq (Takara, Dalian, China). <ref type="bibr" target="#b10">11</ref></s><s>Primer information is provided in Table <ref type="table">S2</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7">| Vector constructs, lentivirus production, and cell transduction</head><p><s>The CD44s ORF sequence was PCR amplified using specific primers MHCC-97L cells were infected with 1 9 10 6 recombinant lentivirus-transducing units in the presence of 6 lg/mL polybrene (Sigma).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.8">| RNA interference</head><p><s>Small-interfering RNA (siRNA) oligos targeting CD44s and a negative control were synthesized and annealed by GenePharma (Shanghai, China).</s><s>Two target sequences of CD44s siRNA, 518 and 688, were selected.</s><s>These sequences were: 5 0 -CCGCTTTGCAGGTGTATTC-3 0 ; and 5 0 -AAATGGTCGCTACAGCATC-3 0 , respectively.</s><s>An siRNA with a non-targeting sequence (scrambled sequence) was used as a negative control (shNC) in our experiment.</s><s>RNA interference was carried out as described previously. 11</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.9">| In vitro migration and invasion assays</head><p><s>For in vitro migration and invasion assays, cells were seeded onto the upper chamber of a transwell or on a Matrigel-coated transwell (BD Biosciences, Franklin Lakes, NJ, USA) in serum-free media.</s><s>The lower chamber contained DMEM with 10% FBS as a chemoattractant.</s><s>After 12 or 48 hours of incubation, non-migrated cells were gently removed from the upper chamber with a cotton swab.</s><s>Cells were fixed and stained using Giemsa solution and counted in 5 randomly chosen visual fields.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.10">| Statistical analysis</head><p><s>Statistical analyses were carried out using SPSS 16.0 software.</s><s>All data are presented as the mean AE SD.</s><s>Two-group comparisons were analyzed using the two-tailed Student's t test.</s><s>Three or more group comparisons were analyzed using one-way ANOVA.</s><s>P &lt; .05 was considered statistically significant.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">| RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">| TM suppresses the proliferation of HCC cells by inducing G2/M arrest</head><p><s>To determine the effects of TM on the proliferation of cells, HCC cells were treated with different concentrations of TM for 48 hours. in a dose-dependent way (Figure <ref type="figure">1E</ref>).</s><s>Therefore, these results</s></p><p><s>showed that TM suppresses the proliferation of HCC cell by inducing G2/M arrest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">| Tunicamycin induces HCC cell apoptosis by</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bcl-2 family proteins</head><p><s>Apoptosis is also widely believed to be the major antiproliferative mechanism of anticancer drugs in many tumor cell types.</s><s>Therefore, we also investigated the effect of TM on HCC cell apoptosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Increased apoptosis was observed in MHCC</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">| Tunicamycin inhibits HCC cell migration through CD44s and the ERK1/2 pathway</head><p><s>Cancer cell migration is one of the crucial events in HCC metastasis.</s></p><p><s>Therefore, we detected the effect of TM on cell migration.</s><s>Our results showed that TM inhibited HCC cell migration (Figure <ref type="figure">3A</ref>).</s></p><p><s>The adhesion molecule CD44 plays a role in cell migration, metastasis and EMT. <ref type="bibr" target="#b11">12</ref> Therefore, we detected the effect of TM on CD44s expression in HCC cells.</s><s>The results showed that TM inhibited expression of CD44s in a time-dependent way in MHCC-97L</s></p><p><s>and MHCC-97H cells (Figure <ref type="figure">3B</ref>).</s><s>In addition, we found that TM treatment of cells partially resulted in morphological changes from scattered growth structures to tightly packed colonies, suggesting the inhibition of EMT (Figure <ref type="figure">3C</ref>).</s><s>To explore the role of CD44s in HCC migration, we first detected the migratory potential of several HCC cell lines using a BD transwell chamber.</s><s>The results showed that the rates of cell migration were much higher in Huh7, MHCC- (Gene Expression Omnibus).</s><s>Our results showed that patients in the high CD44 expression group had shorter overall survival time than patients in the low expression group (log-rank, P = .017,</s><s>Figure <ref type="figure" target="#fig_6">5A</ref>) in publicly available gene expression array datasets (TCGA) using prognostic database PROGgene V2. <ref type="bibr" target="#b12">13</ref> In addition, we found that there was a significant positive correlation between the expression of CD44 and Snail in HCC tissue using data sets from TCGA and GEO (Figure <ref type="figure" target="#fig_6">5B</ref>).</s><s>Furthermore, we found that there was a significant negative correlation between the expression of CD44 and E-cadherin in HCC tissue using data sets from TCGA and GEO (Fig- <ref type="figure" target="#fig_6">ure 5C</ref>).</s><s>Therefore, all of these results suggested that high levels of CD44s expression are related to a high metastatic potential and EMT.</s></p><p><s>To investigate whether the migratory potential of HCC cells was determined by CD44s, a CD44s expression vector was stably The ERK pathway has been implicated in malignant transformation and in the regulation of cellular proliferation and metastasis of several tumor types. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref></s><s>Furthermore, we found that overexpression of CD44s increased ERK1/2 activation in HCC cells (Figure <ref type="figure">S2</ref>).</s><s>Therefore, we detected the expression of ERK1/ 2 in TM-treated HCC cells.</s><s>Results showed that TM inhibited ERK1/2 activation in a time-dependent way in MHCC-97L and MHCC-97H cells (Figure <ref type="figure">3B</ref>).</s><s>Hyaluronic acid (HA) is a major component of the extracellular matrix and can bind to its specific cell surface receptor, CD44. <ref type="bibr" target="#b15">16</ref></s><s>Our results showed that HA increased ERK1/2 activation in a dose-dependent way in MHCC-97L cells (Figure <ref type="figure">6A</ref>).</s><s>The MEK/ERK inhibitor U0126 inhibited HA-induced cell migration in MHCC-97L cells.</s><s>Furthermore, TM also suppressed HA-induced cell migration in MHCC-97L cells (Figure <ref type="figure">6B,   C</ref>).</s><s>Therefore, these results suggested that TM inhibited migration of cells through the CD44s-ERK1/2 pathway and inhibition of EMT.</s></p><formula xml:id="formula_0">F I G U R E 2</formula></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">| Tunicamycin inhibits CD44s glycosylation and reduced its expression</head><p><s>CD44 is a glycosylated protein localized to the apical domain of plasma membranes. <ref type="bibr" target="#b16">17</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">| DISCUSSION</head><p><s>Hepatocellular carcinoma is the most common primary malignancy of the liver in adults and the third most common cause of cancer death worldwide.</s><s>In most cases, death results from metastasis at secondary sites.</s><s>Tumor metastasis is a complex and multistage process, and tumor cells are required to express a variety of properties including altered adhesiveness, increased motility and invasive capacity to complete the metastatic process. <ref type="bibr" target="#b18">19</ref></s><s>EMT is proposed to be a crucial mechanism that regulates the initial steps of metastatic progression. <ref type="bibr" target="#b19">20</ref></s><s>Therefore, interruption of this step may be a strategy for the prevention and treatment of HCC metastasis. <ref type="bibr" target="#b3">4</ref> In the present study, we showed that TM inhibited HCC cell proliferation by inducing G2/ M cell cycle arrest and cell apoptosis.</s><s>TM inhibited the migration of HCC cells by decreasing activation of the CD44s-ERK1/2 signaling pathway.</s></p><p><s>Tunicamycin exerts a direct effect on HCC cells partially through inhibition of CD44.</s><s>CD44 is a transmembrane glycoprotein that includes an extracellular region that interacts with growth factors and HA as well as a cytoplasmic moiety that is capable of interacting with cytoskeletal components. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref></s><s>In this study, we found that TGF-b-promoted migration was reversed following TM treatment.</s><s>Previous studies have also shown that inhibition of CD44 by an anti-CD44 mAb blocks tumor growth, metastasis, and invasion. <ref type="bibr" target="#b22">23</ref></s><s>Furthermore, our previous results also showed that CD44s expression was upregulated in HCC tissues. <ref type="bibr" target="#b23">24</ref></s><s>In addition, a previous study has indicated a shift in CD44 expression from variant isoforms (CD44v) to the standard isoform (CD44s) during EMT. <ref type="bibr" target="#b5">6</ref></s><s>Our results showed that CD44v expression was decreased in TM-treated cells.</s><s>However, CD44s expression was also decreased in TM-treated cells (Figure <ref type="figure">S3</ref>).</s><s>Therefore, we did not that treatment of ovarian cells with a deglycosylating enzyme decreased the binding of CD44 to HA. <ref type="bibr" target="#b24">25</ref> Bartolazzi et al. reported that in melanoma cells, mutation of the CD44 N-linked glycosylation sites inhibited CD44 binding to HA. <ref type="bibr" target="#b25">26</ref> Interactions between CD44, HA, and epidermal growth factor receptor (EGFR) promote the progression of various tumors by cross-activation of several signaling pathways.</s><s>In head and neck squamous cell carcinoma, HA mediates the formation of a complex including CD44 and EGFR. <ref type="bibr" target="#b26">27</ref></s><s>After the HA/CD44 interaction that recruits and forms a CD44-EGFR complex, multiple downstream signaling pathways are activated, further promoting diverse tumor progression behaviors.</s><s>We also found that HA could activate phosphorylation of EGFR.</s><s>In addition, CD44 and EGFR were colocalized in MHCC-97L cells examined by confocal microscopy (Figure <ref type="figure">S4</ref>).</s></p><p><s>EGFR is a glycosylated protein localized to the apical domain of plasma membranes. <ref type="bibr" target="#b27">28</ref></s><s>Our results showed that EGFR is glycosylated in hepatocellular carcinoma cells (Figure <ref type="figure">S4</ref>).</s><s>In addition, we found that TM inhibited EGFR expression by regulating its glycosylation.</s></p><p><s>F I G U R E 5 CD44 is associated with poor prognosis in hepatocellular carcinoma (HCC) patients.</s><s>A, Patients with high expression levels of CD44 had shorter overall survival than patients with low expression levels.</s><s>B, Correlation between CD44 expression and level of Snail in HCC tissues was analyzed using data sets from TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus).</s><s>C, Correlation between CD44 and E-cadherin expression in HCC tissues was analyzed using data sets from TCGA and GEO Furthermore, a recent study also showed that tunicamycin effectively enhanced TRAIL-induced apoptosis possibly through the inhibition of the EGFR pathway in human colon cancer cells. <ref type="bibr" target="#b28">29</ref></s><s>Bourguignon et al.</s></p><p><s>previously reported the notion that CD44 can participate in the activation of EGFR in response to HA in squamous cell carcinoma cells. <ref type="bibr" target="#b29">30</ref></s><s>erefore, we speculated that TM inhibited HCC cell proliferation and migration possibly through regulation of the CD44s-mediated EGFR signaling pathways.</s><s>However, these results need to be confirmed in the future.</s></p><p><s>Here we determined that TM inhibited the proliferation and migration of HCC cells.</s><s>Moreover, we found that TM inhibited the proliferation and migration of HCC cells through attenuated activation of ERK1/2.</s><s>These results will provide supportive evidence to uncover the antitumor mechanisms of TM.</s><s>The ERK1/2 signaling pathway is believed to play an important role in cancer proliferation, apoptosis and migration. <ref type="bibr" target="#b30">31</ref></s><s>The activation of ERK1/2 pathways in the progression of EMT in several cell lines has been widely established. <ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33</ref></s><s>Levels of phosphorylated forms of ERK1/2 are significantly higher in HCC models and human HCC tissue specimens than in healthy liver samples. <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35</ref></s><s>Moreover, MAPK/ERK activity has been shown to be positively correlated with tumor size and aggressive tumor activity, <ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b36">37</ref> suggesting</s></p><formula xml:id="formula_1">F I G U R E<label>6</label></formula></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>(forward: 5 0</head><label>5</label><figDesc><div><p><s>-ATGGACAAGTTTTGGTGGCAC-3 0 ; reverse: 5 0 -TTACA CCCCAATCTTCATGTCC-3 0 ) and cloned into the lentiviral expression vector pWPXL (Addgene, Cambridge, MA, USA) by replacing the GFP fragment.</s><s>Viral packaging was carried out in HEK-293T cells after cotransfection of the pWPXL-CD44s vector with the packaging plasmid psPAX2 and envelope plasmid pMD2.G (Addgene) using Lipofectamine 2000 (Invitrogen).</s><s>The viruses were harvested 72 hours after transfection, and the viral titers were determined.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Figure1A, TM inhibited cell proliferation of HCC cell in a dosedependent way.</s><s>To exclude the possibility that the effect of TM on cell proliferation was occurring as a result of drug toxicity, the effect of TM on the immortalized human liver cell line L02 was also</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>-97L cells treated with TM, implying that an increased rate of apoptosis could be one of the mechanisms of TM inhibition of cell proliferation (Figure 2A).</s><s>To understand the mechanism by which TM induces cell apoptosis, we assessed the expression of Bcl-2 family proteins using western blotting.</s><s>Results showed that the proapoptotic Bcl-2 family proteins Bim and Bid were up-regulated, and that the concomitant anti-apoptosis proteins Bcl-xL and Mcl-1 were down-regulated in TM-treated MHCC-97L cells (Figure 2B).</s><s>However, the expression of Bcl-2 and PDCD4 did not change after TM treatment.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>97L, MHCC-97H and SMMC-7721 cells than in PLC/PRF/5 and Hep3B cells (Figure 4A).</s><s>Notably, most of the highly metastatic cell lines (Huh7, MHCC-97L, MHCC-97H and SMMC-7721) expressed higher levels of CD44s as well as the EMT-related markers Snail and N-cadherin, whereas the low CD44s-expressing cell lines PLC/PRF/5 and Hep3B showed high expression levels of E-cadherin, as determined by western blotting and real-time PCR (Figure 4B; Figure S1).</s><s>Furthermore, we analyzed the expression levels of CD44 (total CD44) and Snail (a major transcription factor governing EMT) F I G U R E 1 Effect of tunicamycin (TM) on hepatocellular carcinoma (HCC) cell growth and cell cycle-related protein expression.</s><s>A, Growth inhibition rates of Huh7, MHCC-97L, MHCC-97H, MHCC-LM3, HCC-LY5, HepG2 and L02 cells resulting from treatment with TM for 48 h.</s><s>B, Cell cycle distribution of MHCC-97L cells that were treated with 2.5 lg/mL TM for 48 h.</s><s>C, After the cells were synchronized with thymidine, cell cycle distribution of MHCC-97L cells was determined by flow cytometry.</s><s>D, After the cells were synchronized with nocadazole, cell cycle distribution of MHCC-97L cells was determined by flow cytometry.</s><s>E, Expression of proliferating cell nuclear antigen (PCNA), CDC-2 and cyclin B1 was detected by western blotting in MHCC-97L cells treated with 2.5 lg/mL TM for the indicated length of time using data sets from TCGA (The Cancer Genome Atlas) and GEO</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>Tunicamycin (TM) induces cell apoptosis and regulates the expression of Bcl-2 family proteins in hepatocellular carcinoma (HCC) cells.</s><s>A, Following treatment of MHCC-97L cells with 2.5 lg/ mL TM for 48 h, apoptotic cells were detected by Annexin V and 7-AAD double staining.</s><s>B, Expression of PDCD4, Bim, Bid, Mcl-1, Bcl-xL and Bcl-2 was detected by western blotting in MHCC-97L cells treated with 2.5 lg/mL TM for the indicated length of time F I G U R E 3 Tunicamycin (TM) inhibits hepatocellular carcinoma (HCC) cell migration through the CD44s and ERK1/2 pathway.</s><s>A, Following treatment of MHCC-97L, MHCC-97H and SMMC-7721 cells with 2.5 lg/mL TM for 48 h, cell migration was detected by transwell assay.</s><s>*P &lt; .05.</s><s>B, Expression of CD44s, p-ERK1/2, ERK1/2, E-cadherin, N-cadherin and Snail was detected by western blotting in MHCC-97L and MHCC-97H cells treated with 2.5 lg/mL TM for the indicated length of time.</s><s>C, Phase-contrast images (2009) show morphological changes in TM-treated MHCC-97L and MHCC-97H cells and control cells.</s><s>D, Expression of CD44s was detected by western blotting in CD44s knockdown MHCC-97L cells or control cells treated with 2.5 lg/mL TM for 12 h.</s><s>E, Migration and invasion were measured using transwell assays with CD44s knockdown MHCC-97L cells or control cells treated with 2.5 lg/mL TM. **P &lt; .01.</s><s>F, Expression of CD44s was detected by western blotting in CD44s overexpressing PLC/PRF/5 cells or control cells treated with 2.5 lg/mL TM for 12 h.</s><s>G, Migration and invasion were measured using transwell assays with CD44s overexpressing PLC/PRF/5 cells or control cells treated with 2.5 lg/mL TM. *P &lt; .05;</s><s>**P &lt; .01</s><s>transfected into PLC/PRF/5 cells.</s><s>Overexpression of CD44s increased the in vitro migration of the transfected cells (Figure 4C, D).</s><s>Conversely, CD44s knockdown inhibited cell migration in HCC cells (Figure 4E,F).</s><s>To confirm the role of CD44s in TM-induced inhibition of the migration of HCC cells, a CD44s siRNA was transfected into MHCC-97L cells.</s><s>Our results showed that the ability of TM to inhibit cell migration and invasion was enhanced in CD44s knockdown cells (Figure 3D,E).</s><s>To exclude the role of endogenous CD44s, a CD44s expression vector was stably transfected into PLC/PRF/5 cells (low expression of CD44s).</s><s>Conversely, the ability of TM to inhibit cell migration and invasion was reversed in cells overexpressing CD44s (Figure 3F,G).</s><s>Furthermore, results showed that up-regulation of E-cadherin and concomitant down-regulation expression of N-cadherin as well as the EMTrelated transcription factor Snail was observed in TM treated cells (Figure 3B).</s><s>Therefore, these results indicated that TM inhibited cell migration by regulating CD44s-mediated EMT in HCC cells.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>Following digestion with the glycosidase PNGase F, western blotting using an anti-CD44 antibody showed the appearance of a new band of approximately 70 kDa, showing that CD44 is glycosylated in HCC cells (Figure 7A,B).</s><s>Then, we detected the expression of CD44s in TM-treated cells.</s><s>A band of about 70 kDa was also observed in TM-treated cells (Figure 7A,B).</s><s>These results showed that the inhibitory effect of TM on the proliferation and migration of HCC cells was partly a result of inhibition of CD44s glycosylation.</s><s>In addition, we also detected the expression of CD44s mRNA in TM-treated HCC cells.</s><s>Our results showed that TM suppressed the expression of CD44s mRNA in HCC cells (Figure 7C).</s><s>Therefore, these results suggest that TM inhibits the proliferation and migration of HCC cells by decreasing CD44s expression and altering its glycosylation.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>3. 5 |</head><label>5</label><figDesc><div><p><s>Tunicamycin inhibits transforming growth factor beta-mediated cell migrationBecause transforming growth factor beta (TGF-b) signaling is one of the major driving factors of EMT in HCC,<ref type="bibr" target="#b17">18</ref> we speculated that inhibition of TM during EMT might be attributed to a blockade of endogenous TGF-b signaling.</s><s>Our results showed that TGF-b induced EMT of HCC cells by increasing expression of Ncadherin and Snail, decreasing E-cadherin expression.</s><s>At the same time, expression of CD44s and p-ERK1/2 also was upregulated in TGF-b-treated cells (Figure8A).</s><s>Transwell assays also showed that TGF-b promoted cell migration in MHCC-97L cells (Figure8B).</s><s>However, TGF-b-promoted migration was reversed following TM treatment (Figure8B).</s><s>Furthermore, TM also inhibited the expression of CD44s, p-ERK1/2, N-cadherin and Snail in TGF-b-treated MHCC-97L cells (Figure8A).</s><s>Therefore, these results showed that TM inhibited TGF-b-mediated cell migration in HCC cells.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc><div><p><s>observe the shift in CD44 expression from CD44v to CD44s in TM-treated cells.</s><s>Considering the accumulating body of evidence F I G U R E 4 CD44s expression is associated with a mesenchymal phenotype and migratory ability in hepatocellular carcinoma (HCC) cells.</s><s>A, Highly metastatic cell lines have higher migration potential than less metastatic cell lines.</s><s>B, Expression of CD44s, E-cadherin, N-cadherin and Snail was detected by western blotting in HCC cell lines.</s><s>C, Expression levels of CD44s, E-cadherin and N-cadherin were detected by western blotting in CD44s-overexpressing PLC/PRF/5 cells.</s><s>D, Cell migration was measured using transwell assays in CD44s-overexpressing PLC/PRF/ 5 cells.</s><s>E, Expression levels of CD44s, E-cadherin and N-cadherin were detected by western blotting in CD44s-knockdown MHCC-97L cells.</s><s>F, Cell migration was measured using transwell assays in CD44s-knockdown MHCC-97L cells.</s><s>**P &lt; .01 that highlights the important role of CD44s signaling in tumor progression, disrupting CD44s-mediated signaling pathways may lead to improved treatment of HCC.</s><s>Glycosylation of the CD44 molecule causes conformational changes that may affect its ability to bind to HA. Katoh et al. found</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head></head><label></label><figDesc><div><p><s>Tunicamycin (TM) inhibits hyaluronic acid (HA)-induced cell migration by suppressing ERK1/2 activity in MHCC-97L cells.</s><s>A, Expression levels of p-ERK1/2 and ERK1/2 were detected by western blotting in MHCC-97L cells treated with 50 lg/mL HA for the indicated length of time.</s><s>B, Expression levels of p-ERK1/2 and ERK1/2 were detected by western blotting in MHCC-97L cells treated with 2.5 lg/mL TM, 50 lg/mL HA or 10 lmol/L U0126 alone or in combination for 12 h.</s><s>C, MHCC-97L cells were treated with 2.5 lg/mL TM, 50 lg/mL HA or 10 lmol/L U0126 alone or in combination for 12 h, and migration was measured using transwell assays.</s><s>*P &lt; .05 that ERK1/2 activation reflects aggressive tumor activity in clinical conditions.</s><s>Furthermore, we found that CD44s can activate the phosphorylation of ERK1/2 in HCC cells.</s><s>Therefore, we showed that TM inhibited the CD44-ERK1/2 signaling pathway to regulate the proliferation and migration of HCC cells.</s><s>Therefore, TM could be used as a potential agent against HCC metastasis.</s><s>In conclusion, our study suggests that the glycosylation inhibitor TM attenuates the proliferative and migratory abilities of HCC through the CD44s and ERK1/2 dependent pathway.</s><s>CD44s or its F I G U R E 7 Tunicamycin (TM) inhibits CD44 expression and alters its glycosylation.</s><s>A, MHCC-97L and MHCC-97H cell lysates were treated with PNGase F, Endo Hf, or a-2,3-neuraminidase at 37°C according to the datasheets.</s><s>Shift in CD44 molecular weight was detected by western blotting.</s><s>B, Expression level of CD44s was detected by western blotting in SMMC-7721 and MHCC-97L cells treated with 2.5 lg/mL TM for 24 h.</s><s>C, Expression of CD44s was detected by real-time PCR in MHCC-97L, MHCC-97H and SMMC-7721 cells treated with 2.5 lg/ mL TM for 24 h.</s><s>*P &lt; .05;</s><s>**P &lt; .01</s><s>F I G U R E 8 Tunicamycin (TM) inhibits transforming growth factor (TGF)-b-induced cell migration by suppressing ERK1/2 activity and CD44 expression in MHCC-97L cells.</s><s>A, Expression levels of CD44s, p-ERK1/2, ERK1/2, E-cadherin, N-cadherin and Snail were detected by western blotting in MHCC-97L cells treated with 2.5 lg/mL TM or 5 lg/L TGF-b for 12 h.</s><s>B, Following the treatment of MHCC-97L cells with 2.5 lg/ mL TM or 5 lg/L TGF-b for 12 h, cell migration was detected by transwell assay.</s><s>** P &lt; .01</s><s>downstream effector ERK1/2 might be able to be used as novel therapeutic targets for HCC therapy.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="9,46.49,52.47,331.92,526.21" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="11,49.32,52.47,498.96,249.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="11,49.32,401.13,498.96,190.80" type="bitmap" /></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONF LICTS OF INTEREST</head></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="2072" to="2077" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A perspective on cancer cell metastasis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Chaffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Weinberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">331</biblScope>
			<biblScope unit="page" from="1559" to="1564" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Molecular mechanisms of liver metastasis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kawada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hasegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Murakami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="464" to="472" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Regulatory networks defining EMT during cancer initiation and progression</title>
		<author>
			<persName><forename type="first">B</forename><surname>De Craene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Berx</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="97" to="110" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">CD44 in cancer progression: adhesion, migration and growth regulation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Marhaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zoller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Histol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="211" to="231" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">CD44 splice isoform switching in human and mouse epithelium is essential for epithelialmesenchymal transition and breast cancer progression</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Reinke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Damerow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="1064" to="1074" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival</title>
		<author>
			<persName><forename type="first">K</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Terada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hepatol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="78" to="84" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: from patients to patient-derived tumor xenograft models</title>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="47431" to="47443" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Parodi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem J</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cancer Ther</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="2874" to="2884" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1459" to="1470" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Role of CD44 in tumour progression and strategies for targeting</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Negi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Talegaonkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jaggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Ahmad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Iqbal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Khar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Drug Target</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="561" to="573" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">PROGgeneV2: enhancements on the existing database</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Goswami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nakshatri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">970</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Calcium binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating ERK signaling pathway</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="1529" to="1545" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">A double-negative feedback loop between EpCAM and ERK contributes to the regulation of epithelial-mesenchymal transition in cancer</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Sankpal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Wiedner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Gillanders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="3706" to="3717" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ahrens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Assmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fieber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Invest Dermatol</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="93" to="101" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Mass spectrometry (LC-MS/MS) sitemapping of N-glycosylated membrane proteins for breast cancer biomarkers</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Whelan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Proteome Res</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="4151" to="4160" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">CD44s regulates the TGF-betamediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Okabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ishimoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="3414" to="3423" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Molecular targeted therapies in hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Llovet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bruix</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1312" to="1327" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">TGF-beta in epithelial to mesenchymal transition and metastasis of liver carcinoma</title>
		<author>
			<persName><forename type="first">P</forename><surname>Reichl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Haider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grubinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mikulits</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Pharm Des</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="4135" to="4147" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Bourguignon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cancer</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">52</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Bourguignon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Small GTPases</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="53" to="59" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Differential splicing generates new transmembrane receptor and extracellular matrix-related targets for antibody-based therapy of cancer</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">H</forename><surname>Weidle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Maisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klostermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schmitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Genomics Proteomics</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="211" to="226" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Downregulation of AZGP1 by Ikaros and histone deacetylase promotes tumor progression through the PTEN/Akt and CD44s pathways in hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Carcinogenesis</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="207" to="217" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Glycosylation of CD44 negatively regulates its recognition of hyaluronan</title>
		<author>
			<persName><forename type="first">S</forename><surname>Katoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Oritani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimozato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Kincade</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="page" from="419" to="429" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bartolazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nocks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aruffo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Stamenkovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biol</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="1199" to="1208" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Bourguignon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="page" from="956" to="963" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Role of Nglycosylation in EGFR ectodomain ligand binding</title>
		<author>
			<persName><forename type="first">Azimzadeh</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kannan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proteins</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="1529" to="1549" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway</title>
		<author>
			<persName><forename type="first">X</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anticancer Drugs</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="66" to="74" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2 + signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Bourguignon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gilad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brightman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Diedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Singleton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="page" from="14026" to="14040" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">ERK1/2 MAP kinases: structure, function, and regulation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Roskoski</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Res</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="105" to="143" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">ERK1/2 pathway mediates epithelial-mesenchymal transition by cross-interacting with TGFbeta/Smad and Jagged/Notch signaling pathways in lens epithelial cells</title>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xiao</forename><forename type="middle">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Mol Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1664" to="1670" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">ERK1/2 blockade prevents epithelialmesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Buonato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lazzara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Res</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="309" to="319" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Mckillop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Cahill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Sitzmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1484" to="1491" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Horimoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="951" to="958" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Schmitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wohlschlaeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hepatol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="83" to="90" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor</title>
		<author>
			<persName><forename type="first">D</forename><surname>Dominguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Montserrat-Sentis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Virgos-Soler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="5078" to="5089" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title/>
		<author>
			<persName><surname>S U P P O R T I N G I N F O R M A T I O N</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
